Department of Pediatrics

Education

• BA, St. Louis University, 2009
• MD, St. Louis University School of Medicine, 2013

Training

• Pediatric and Adolescent Medicine Residency, Mayo Clinic, 2013 - 2016
• Research Fellow, Mayo Clinic, 2016 - 2017
• Pediatric Cardiology Fellowship, Mayo Clinic, 2017 - 2020
• Pediatric Cardiology Advanced Imaging Fellow, Children's Hospital of Wisconsin, 2020 - 2021

Licensure and Board Certification

• Neonatal Resuscitation Certification
• Pediatric Advanced Life Support - Instructor
• 2016General Pediatrics, American Board of Pediatrics
• 2020MO, The American Board of Pediatrics Cardiology
• 2021 - 2022MO, Medical License

Honors and Awards

• Gunnar B. Stickler Award for Excellence in Patient Care, 2016
• James W. DuShane Award for Excellence in Medical Education, 2016
• American Academy of Pediatrics Young Investigator Award, 2017

Recent Publications view all (18)

1. Rohatgi RK, Qureshi MY, Taggart NW. Limited Utility of Surveillance Echocardiograms in Pediatric Patients with Isolated Secundum Atrial Septal Defects. J Am Soc Echocardiogr. 2021;34(2):197-199. PMID:33188870 
2. MacIntyre CJ, Rohatgi RK, Sugrue AM, Bos JM, Ackerman MJ. Intentional nontherapy in long QT syndrome. Heart Rhythm. 2020;17(7):1147-1150. PMID:32105774 
3. Giudicessi JR, Rohatgi RK, Tester DJ, Ackerman MJ. Variant Frequency and Clinical Phenotype Call Into Question the Nature of Minor, Nonsyndromic Long-QT Syndrome-Susceptibility Gene-Disease Associations. Circulation. 2020;141(6):495-497. PMID:32078429 
4. Anderson HN, Bos JM, Rohatgi RK, Ackerman MJ. The Effect of Left Cardiac Sympathetic Denervation on Exercise in Patients With Long QT Syndrome. JACC Clin Electrophysiol. 2019;5(9):1084-1090. PMID:31537339 
5. Bos JM, Crotti L, Rohatgi RK, Castelletti S, Dagradi F, Schwartz PJ, Ackerman MJ. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. Circ Arrhythm Electrophysiol. 2019;12(5):e007280. PMID:31006312 
6. Giudicessi JR, Lieve KVV, Rohatgi RK, Koca F, Tester DJ, van der Werf C, Martijn Bos J, Wilde AAM, Ackerman MJ. Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance. Circ Genom Precis Med. 2019;12(5):e002510. PMID:31112425 
7. Clemens DJ, Tester DJ, Giudicessi JR, Bos JM, Rohatgi RK, Abrams DJ, Balaji S, Crotti L, Faure J, Napolitano C, Priori SG, Probst V, Rooryck-Thambo C, Roux-Buisson N, Sacher F, Schwartz PJ, Silka MJ, Walsh MA, Ackerman MJ. International Triadin Knockout Syndrome Registry. Circ Genom Precis Med. 2019;12(2):e002419. PMID:30649896 
8. Giudicessi JR, Rohatgi RK, Bos JM, Ackerman MJ. Prevalence and clinical phenotype of concomitant long QT syndrome and arrhythmogenic bileaflet mitral valve prolapse. Int J Cardiol. 2019;274:175-178. PMID:30219255 
9. Lane CM, Bos JM, Rohatgi RK, Ackerman MJ. Beyond the length and look of repolarization: Defining the non-QTc electrocardiographic profiles of patients with congenital long QT syndrome. Heart Rhythm. 2018;15(9):1413-1419. PMID:29723683 
10. Sugrue A, Rohatgi RK, Bos M, Vaidya VR, Asirvatham SJ, Noseworthy PA, Ackerman MJ. Clinical Significance of Early Repolarization in Long QT Syndrome. JACC Clin Electrophysiol. 2018;4(9):1238-1244. PMID:30236400 
11. Lane CM, Giudicessi JR, Ye D, Tester DJ, Rohatgi RK, Bos JM, Ackerman MJ. Long QT syndrome type 5-Lite: Defining the clinical phenotype associated with the potentially proarrhythmic p.Asp85Asn-KCNE1 common genetic variant. Heart Rhythm. 2018;15(8):1223-1230. PMCID:PMC6402333  PMID:29625280 
12. Turkowski KL, Bos JM, Ackerman NC, Rohatgi RK, Ackerman MJ. Return-to-Play for Athletes With Genetic Heart Diseases. Circulation. 2018;137(10):1086-1088. PMID:29507000 
13. Sugrue A, Rohatgi RK, Noseworthy PA, Kremen V, Bos JM, Qiang B, Sapir Y, Attia ZI, Scott CG, Brady P, Asirvatham SJ, Friedman PA, Ackerman MJ. Architectural T-Wave Analysis and Identification of On-Therapy Breakthrough Arrhythmic Risk in Type 1 and Type 2 Long-QT Syndrome. Circ Arrhythm Electrophysiol. 2017;10(11). PMID:29141844 
14. Sugrue A, Noseworthy PA, Kremen V, Bos JM, Qiang B, Rohatgi RK, Sapir Y, Attia ZI, Brady P, Caraballo PJ, Asirvatham SJ, Friedman PA, Ackerman MJ. Automated T-wave analysis can differentiate acquired QT prolongation from congenital long QT syndrome. Ann Noninvasive Electrocardiol. 2017;22(6). PMCID:PMC6931613  PMID:28429460 
15. Roberts JD, Krahn AD, Ackerman MJ, Rohatgi RK, Moss AJ, Nazer B, Tadros R, Gerull B, Sanatani S, Wijeyeratne YD, Baruteau AE, Muir AR, Pang B, Cadrin-Tourigny J, Talajic M, Rivard L, Tester DJ, Liu T, Whitman IR, Wojciak J, Conacher S, Gula LJ, Leong-Sit P, Manlucu J, Green MS, Hamilton R, Healey JS, Lopes CM, Behr ER, Wilde AA, Gollob MH, Scheinman MM. Loss-of-Function KCNE2 Variants: True Monogenic Culprits of Long-QT Syndrome or Proarrhythmic Variants Requiring Secondary Provocation? Circ Arrhythm Electrophysiol. 2017;10(8). PMID:28794082 
16. Rohatgi RK, Sugrue A, Bos JM, Cannon BC, Asirvatham SJ, Moir C, Owen HJ, Bos KM, Kruisselbrink T, Ackerman MJ. Contemporary Outcomes in Patients With Long QT Syndrome. J Am Coll Cardiol. 2017;70(4):453-462. PMID:28728690 
17. Sugrue A, Noseworthy PA, Kremen V, Bos JM, Qiang B, Rohatgi RK, Sapir Y, Attia ZI, Brady P, Asirvatham SJ, Friedman PA, Ackerman MJ. Identification of Concealed and Manifest Long QT Syndrome Using a Novel T Wave Analysis Program. Circ Arrhythm Electrophysiol. 2016;9(7). PMID:27406603 
18. Rohatgi RK, Bos JM, Ackerman MJ. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination? Heart Rhythm. 2015;12(8):1807-12. PMCID:PMC5084529  PMID:25956966